AVAILABILITY:

WorldHeart's PediaFlow VAD is not currently available for sale or investigational use.

STATUS:

In 2007 and 2008, WorldHeart and its R&D consortium members for the PediaFlow VAD achieved several development milestones including acute and chronic animal trials with the two iterations of PediaFlow VAD prototypes. This set of milestones and ongoing work on the miniature PediaFlow VAD clinical prototype has laid the groundwork for the development of a prototype MiVAD pump in 2009.

Overview

Levacor VAD™

MiVAD

Technologies

Minimally Invasive VAD (MIVAD)

PediaFlow VAD

PediaFlow Consortium

The PediaFlow VAD is being developed by a multi-disciplinary and multi-institutional consortium.

The consortium members form a team with decades of experience and world-class accomplishments in the blood pump field. The members are:

Pittsburgh, PA	Pittsburgh, PA
Goleta, CA	Salt Lake City, UT and Oakland, CA
Pittsburgh, PA	Pittsburgh, PA
Salt Lake City, UT

The PediaFlow VAD Consortium is funded by a $4.5M contract from NIH. It is one of five such contracts awarded in the United States.

The Principal Investigator on the NIH Contract is Dr. Harvey Borovetz of the University of Pittsburgh. Dr. Borovetz is chairman of the Department of Bioengineering and is a faculty at the Department of Surgery at the University of Pittsburgh Medical Center (UPMC).

For further information on the PediaFlow VAD, please visit the LaunchPoint Technologies website at: www.launchpnt.com/portfolio/pediaflow-vad.html.